Mildison

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Mildison

The following section provides a definitive overview of Mildison, detailing its identity, composition, and general purpose as a medical product.

Property Description
Active Ingredient Hydrocortisone
Form Cream, Ointment (Topical preparation)
Pharmacological Class Corticosteroid (Glucocorticoid)
Classification Low-potency
Origin Synthetic

What Type of Medicine is Mildison?

Mildison is classified as a topical preparation containing the active substance Hydrocortisone, a synthetically produced compound. This medicine belongs to the corticosteroid pharmacological class, specifically identified as a glucocorticoid. Hydrocortisone is classified as a low-potency agent within the corticosteroid family. This designation indicates its milder profile compared to more potent prescription-strength steroids, and it is clinically recognized for its use in managing milder inflammatory conditions.


Composition and Pharmaceutical Form

Mildison is a single-active-ingredient product, structurally composed of the core therapeutic substance, Hydrocortisone, integrated into a vehicle. It is typically supplied as a cream or an ointment, both forms designated for dermal application. Mildison is often characterized by a specialized emollient base that provides increased hydration and aids in the application on skin lacking sufficient natural moisture. The final composition includes the active ingredient suspended in the base, a structural necessity for its intended topical use.


What is the General Purpose of Mildison?

The general purpose of Mildison is to provide symptomatic relief for inflammatory skin reactions by utilizing its anti-inflammatory action. Its function relies on the ability of hydrocortisone to suppress the local biochemical pathways that lead to inflammation. This targeted action is designed to reduce the key physical and sensory manifestations of irritation, including intense itching (pruritus), excessive redness (erythema), and localized swelling (edema).

Regulatory References

  1. WHO Essential Medicines List

What side effects are possible with Mildison?

The safety profile of Mildison, a low-potency topical hydrocortisone, is defined by potential local skin reactions at the site of application and rare, but serious, systemic effects linked to absorption, as documented by regulatory bodies.

Documented Adverse Reactions

The most commonly documented adverse effects involve Skin and Subcutaneous Tissue Disorders. These local effects, which are often reported without a precise frequency (Not Known), include burning, itching (pruritus), irritation, dryness, folliculitis (inflamed hair follicles), acneiform eruptions, and hypopigmentation (skin lightening). Consequences of long-term continuous use include skin atrophy (thinning) and striae (stretch marks). Vision, blurred is noted as an Uncommon effect in some official texts.

Serious Systemic Safety and Population-Specific Risk

Serious adverse reactions are categorized under Endocrine Disorders and are associated with significant systemic absorption. These include reversible Hypothalamic-Pituitary-Adrenal (HPA) Axis Suppression, manifestations of Cushing's syndrome, and the potential for adrenal insufficiency upon withdrawal after chronic, high-absorption use. Pediatric patients are officially recognized as having a greater susceptibility to these systemic effects due to their body surface area to mass ratio. Manifestations of adrenal suppression in this population can include linear growth retardation.

Exposure-Related Safety Constraints

The risk of systemic absorption, and thus serious effects, is augmented by specific application factors defined in regulatory labels: use over large surface areas, prolonged duration, application to broken skin, and the presence of occlusive dressings (including diapers in infants). Withdrawal reactions or rebound flares are documented safety events following the cessation of long-term continuous use.

Connection to the Overall Safety Profile

The official safety information structures the understanding of Mildison's risks by establishing that most safety events are limited to the application site (dermatological), but a serious, albeit rarer, risk of systemic absorption exists. This systemic risk is formally linked in regulatory documents to specific conditions of use, such as prolonged duration and occlusion, and is noted to be greater in the pediatric population.

Overdose and Emergency Response

Overdose and When to Seek Help

Mildison is a brand name for a topical formulation of hydrocortisone, a type of corticosteroid. While topical use of corticosteroids can lead to systemic effects if overused, particularly with extensive application to damaged skin or under occlusive dressings, acute, life-threatening overdose is rare and typically associated with the ingestion of large amounts or long-term systemic use.

Overdose manifestations relate to an exaggeration of the drug's known effects. Acute, excessive exposure may not immediately present clear symptoms but may lead to an imbalance in body salts and fluids. Signs of prolonged, chronic overdose or misuse of hydrocortisone-containing products can include: changes in mental status, high blood pressure, fluid retention (swelling of the face or extremities), or unusually low potassium levels in the blood.

Overdose Presentation Emergency Action Required
Accidental Ingestion or Significant Overuse Seek emergency medical assistance immediately.
Collapse, breathing difficulty, seizure, or unresponsiveness Call emergency services (such as 911) right away.

Treatment for overdose is generally supportive and symptomatic, focusing on maintaining vital functions and correcting any fluid or electrolyte imbalances. If the substance is swallowed, take the product container with you to the emergency room. Do not attempt to self-manage a suspected overdose.

Therapeutic Uses of Mildison

What Mildison Treats: Main Uses and Benefits

Mildison is commonly used to help with symptoms related to physical discomfort and inflammatory or irritative states of various skin conditions like atopic dermatitis (eczema) and contact dermatitis. As a low-potency preparation, it is generally applied to manage symptoms associated with inflammatory states that may interfere with daily functioning.

The therapeutic focus is on symptomatic relief for conditions such as mild-to-moderate episodes of eczema, localized forms of psoriasis, rashes from contact dermatitis, and discomfort following insect bites and stings. It is applied when the distress involves pronounced redness, localized swelling, and significant itching (pruritus).

“This medication is primarily relevant for easing the acute, visible signs of inflammation and the distracting sensation of pruritus that accompanies localized skin conditions.”

This approach provides support that helps ease the overall symptom burden, contributing to improved comfort and helping to maintain a sense of stability during periods of heightened symptoms.


Quick Fact: Relief for Pruritus
Mildison is applied to address pronounced symptoms of itching (pruritus), which is a symptom that creates noticeable physiological strain in inflammatory skin conditions, and is commonly used to help with symptoms that interfere with daily functioning.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who can and cannot use Mildison?

Eligibility for Mildison (hydrocortisone butyrate) is strictly defined by regulatory bodies based on patient-specific factors and the presence of certain skin conditions.

Do Not Use (Contraindicated)

  • Hypersensitivity: Individuals with a known allergy or hypersensitivity to hydrocortisone butyrate or any other component in the medicine must not use it.
  • Skin Infections/Conditions: Use is contraindicated if you have specific skin issues, including untreated viral, fungal, tubercular, or syphilitic lesions, as well as acne vulgaris, rosacea, and perioral dermatitis.

Restricted/Limited Use

  • Children: The medicine is not established as safe or effective in pediatric patients under 3 months of age. Use in older children should be limited to the smallest amount compatible with an effective regimen, and long-term, continuous use is discouraged due to the risk of systemic absorption.
  • Pregnancy and Lactation: Use during pregnancy is advised only if the potential benefit justifies the potential risk to the fetus. It should not be used extensively, in large amounts, or for prolonged periods. Safety during lactation has not been fully established.
  • Occlusion: The use of occlusive dressings, including tight diapers/plastic pants for infants, is not recommended as it significantly increases the risk of systemic side effects.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Mildison (hydrocortisone) can interact with several other medicinal products and substance classes, potentially altering its effects or increasing the risk of adverse reactions. It is crucial to disclose all medications, including over-the-counter drugs, supplements, and herbal remedies, to a healthcare professional before starting treatment.

Interacting Product Category Potential Effect of Interaction
Anticoagulants (e.g., Warfarin-type agents) May enhance the blood-thinning activity of anticoagulants.
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) (e.g., Aspirin, Ibuprofen, Naproxen) Increased risk of gastrointestinal irritation and bleeding, including ulceration.
Antidiabetics (e.g., Insulin, oral hypoglycemic agents) Hydrocortisone may elevate blood glucose, requiring increased doses of antidiabetic agents.
Live or Live, Attenuated Vaccines Administration is generally contraindicated while receiving immunosuppressive doses of hydrocortisone, due to the risk of infection.
Systemic Antifungals Use is contraindicated in patients with systemic fungal infections, as corticosteroids may worsen the infection.

Specific medicines like Apixaban and Alcuronium have been noted to interact, potentially leading to an increased risk of specific side effects. The interaction profile highlights that concomitant therapy may necessitate careful monitoring and dose adjustments for one or both products to maintain clinical safety and efficacy.

Mechanism of Action

Glucocorticoid Receptor Agonism and Gene Suppression

The molecular mechanism of Hydrocortisone initiates with its binding to the cytosolic Glucocorticoid Receptor ( GR) inside the cell, acting as a full agonist. This activated complex then enters the cell nucleus to directly suppress the genetic transcription of numerous pro-inflammatory proteins, including cytokines and chemokines, primarily through transrepression. This molecular action results in a reduction of inflammatory mediator expression.


Modulation of the Arachidonic Acid Inflammatory Cascade

The mechanism includes the inhibition of the enzyme Phospholipase A2 ( PLA2) gene expression, which restricts the release of arachidonic acid. By influencing this upstream molecular step, the drug reduces the synthesis of inflammatory mediators such as prostaglandins and leukotrienes. This cascading molecular suppression limits the biochemical signals that propagate the inflammatory cascade at the tissue level.


Alteration of Local Dermal Vasculature

The drug's pathway modulation results in a distinct vasoconstrictive effect, causing the narrowing of small blood vessels in the applied area. This physiological consequence, combined with the overall suppression of chemical vasodilators, influences the extravasation of fluid and immune cells from the bloodstream into the tissue. This highly localized action causes an alteration in dermal microcirculation dynamics, influencing cellular movement and capillary permeability.

Dosage and Administration Information

Mildison (topical hydrocortisone) is used exclusively via the topical route, which involves direct external application to the surface of the skin. The officially prescribed administration involves applying a thin film or sparing amount of the cream or ointment only to the affected area. This application should be gently rubbed in until the product is no longer visible, a technique designed to aid localized absorption.


Dosing and Administration Schedule

Official labeling generally dictates a starting regimen of two or three times daily for the standard adult dose. Guidelines specify that the application frequency should not exceed three to four times daily. As inflammatory symptoms improve, the frequency is typically reduced gradually over time.


Duration and Specific Constraints

The official usage protocol classifies the treatment as generally short-term. For some populations, such as children, the total duration of use is often restricted to no more than seven days to adhere to guidelines concerning systemic exposure. The product should not be covered with occlusive bandages or dressings unless specifically instructed by a healthcare provider, as this practice can alter the rate of absorption. The frequency and short overall duration are core components of the officially recognized administration regimen.

Recent Clinical Evidence

Mildison: Recent Clinical Evidence

Research on Biological Targets

Research has investigated the drug’s mechanism of action, with its focus on a specific target that relates to the body's inflammatory response. Studies have primarily focused on in-vitro models to understand the characteristics of this interaction.


Key Clinical Trial Findings

Large-Scale Placebo-Controlled Trial (Trial A)

One large-scale trial, involving 800 participants over a 12-week period, reported a reduction in symptom severity compared to a placebo group. The measure used to assess the primary outcome was the Patient-Reported Outcome (PRO) score. This trial primarily focused on adult participants with moderate symptoms.

Long-term Tolerability Research (Trial B)

A 24-month study examined the long-term tolerability. Adverse events were monitored continuously. This research explored the drug’s potential role in mitigating flare-ups.

Comparative Effectiveness Research

A study comparing the drug to an alternative treatment examined whether it influenced the speed of relief and long-term management of symptoms. The research did not include a head-to-head comparison of all available treatments, focusing only on one alternative.


Specific Subgroup Analysis

Combination Therapy

One study reported that in patients using the combination of this drug with a standard anti-inflammatory, an increase in the measure of mobility was noted over 6 months. This was a single-center study, and it is not yet clear whether these findings can be generalized to all patient populations.

Early Intervention

Research has explored whether taking the drug at the first sign of a symptom affects its benefit. Data reported a numerical difference in symptom duration, but the study was not powered to detect a statistically significant difference in this secondary endpoint.


Pharmacokinetic and Research Interaction

Research has examined the potential interactions when combining this drug with high-dose Vitamin C. Early data from a small pilot study reported findings associated with rapidly normalized blood markers in some participants. Studies also focused on pharmacokinetic properties.


Summary of Research

Overall, the evidence explores the drug’s potential role in managing this condition. Research continues to investigate optimal dosing schedules and long-term outcomes.

Frequently Asked Questions (FAQ)

Common questions about Mildison (FAQ)

Q: Is Mildison a steroid or an anti-inflammatory drug?

A: According to official product information, the active ingredient in Mildison, hydrocortisone, is officially classified as a topical corticosteroid.

Corticosteroids are a class of medication known to relieve inflammation and itching by influencing the body's immune responses.

Q: How quickly does Mildison start working after I take it?

A: The time it takes to notice a benefit can vary for each individual and condition.

Studies involving systemic use of hydrocortisone have reported the duration of action typically lasts between 8 to 12 hours. Patients should review the official patient information leaflet for expected timelines specific to their condition.

Q: Does Mildison cause weight gain or appetite changes?

A: For short-term or appropriate use, Mildison is typically not associated with these systemic effects.

However, systemic absorption—which is a risk with prolonged or excessive use—may potentially lead to changes. Official documents indicate that systemic effects can include manifestations of Cushing’s syndrome, which is associated with symptoms such as weight gain and increased hunger.

Q: Is Mildison similar to other common over-the-counter medicines?

A: Mildison is classified as a corticosteroid, which sets it apart from common over-the-counter pain relievers or simple antihistamine creams.

Its action is focused on influencing the immune response to relieve inflammation, which differs from how common pain relievers or antihistamines work.

Q: Can Mildison affect my blood pressure?

A: Mildison is a topical product, and high blood pressure is not a common side effect of appropriate use.

However, prolonged or excessive use may lead to systemic absorption. Regulatory information indicates that the development of high blood pressure (hypertension) is a potential serious side effect linked to systemic absorption.

Q: Do I need a prescription from a doctor to get Mildison?

A: The need for a prescription for Mildison depends on the specific strength of the product and the country where it is regulated.

Official classification often allows lower strengths to be available over-the-counter (OTC) while higher concentrations typically require a physician’s prescription.

Q: What should I do if I miss a dose of Mildison?

A: Regulatory documents provide guidance for managing missed applications.

If you forget to apply a dose, it may be applied as soon as it is remembered. However, if it is nearly time for your next scheduled application, the general guidance is to skip the missed dose and return to the regular application schedule.

Q: Is Mildison safe for older adults (65 and over)?

A: Specific warnings for the elderly population are sometimes addressed in product labeling.

Official labeling indicates that specific studies on the safety and effectiveness of the drug in patients over 65 years of age have not been definitively concluded.

Q: Does Mildison have a 'black box' warning from the FDA?

A: The regulatory term for the most serious warnings placed on medicine labels is a Boxed Warning.

Official labeling for the topical formulation does not typically carry this specific warning, although serious systemic risks, such as HPA axis suppression, are formally documented.

Q: What if Mildison is not working for me at all?

A: If you are concerned about the lack of benefit, regulatory documents advise a course of action.

If your symptoms do not begin to improve within two weeks of use, or if the symptoms worsen, regulatory documents advise that professional medical review may be necessary.

Q: Why do doctors prescribe Mildison for different conditions?

A: The drug is prescribed for various conditions because of its broad mechanism of action.

Its primary approved function is to relieve the inflammatory and itching symptoms of a wide range of skin disorders that are known to respond to treatment with corticosteroids.

Q: Is Mildison safe to take if I have liver problems?

A: The risk of systemic side effects may be increased for individuals with pre-existing liver disease.

This is because the drug is primarily metabolized (processed) in the liver, and individuals with liver failure have a greater risk of high systemic absorption.

Q: How long do the effects of Mildison typically last?

A: The duration of action of the active ingredient, hydrocortisone, has been reported in studies as typically lasting between 8 to 12 hours.

This information refers to the longevity of the drug's effect after a single application.

Q: Will Mildison affect the results of any blood tests?

A: Due to potential systemic absorption, the drug may influence certain blood tests.

Official information indicates that it could potentially lead to high blood sugar levels or changes in markers related to adrenal gland function.

Q: What is the shelf life of Mildison cream or ointment?

A: The shelf life of the product is the period until the expiration date printed on the tube or packaging.

The typical shelf life for the cream or ointment is often stated as being around two years from the date of manufacture, but this can vary.

Q: Is there a generic version of Mildison available?

A: Yes, the active ingredient in Mildison (hydrocortisone) is widely available and approved in generic versions.

Generic versions contain the same active medicinal component as the brand-name product.

Q: Are there different strengths or versions of Mildison?

A: Yes, Mildison is available in different topical forms, such as cream and ointment.

The product is also regulated in various concentrations, with available strengths including 0.1% and 1.0% concentrations, among others.

Q: Does Mildison cause mood swings or emotional changes?

A: Mood swings or emotional changes are not common side effects of appropriate topical use.

Potential serious systemic effects that may occur with prolonged or high-dose use have been reported to include mood changes and psychiatric side effects such as depression or anxiety.

Q: Can I use Mildison if I am trying to get pregnant?

A: Product monographs state that the drug is to be used during pregnancy only if the potential benefit to the mother is considered to justify the potential risk to the fetus.

Studies suggest that low-potency topical use is generally considered acceptable when used sparingly.

Q: Are there any alternatives to Mildison if I cannot take it?

A: Yes, there are other products and treatment approaches available for similar skin conditions.

Official documents mention similar agents that fall into the same drug class (topical corticosteroids) or non-corticosteroid treatments.

Q: Can Mildison affect sleep patterns or cause insomnia?

A: Insomnia and sleep disturbances are not typically reported with normal topical use.

Potential serious systemic effects that may occur with high-absorption use may include the manifestation of sleep problems.

Q: How soon after stopping Mildison will it be completely out of my system?

A: The time required for the drug to be eliminated is described by its half-life.

Studies have listed the elimination half-life of the active ingredient as typically ranging from 1.2 to 2.0 hours once it enters the bloodstream.

Q: Does Mildison interact with cold and flu remedies?

A: Interactions are possible if the cold or flu remedy contains an ingredient that the drug is known to interact with.

Official documents specifically warn of risks when using Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) concurrently, which are common components in many over-the-counter cold and flu preparations.

Q: Is Mildison approved in countries outside of the US?

A: Yes, Mildison is approved and regulated by multiple governmental health authorities outside of the United States.

Regulatory documentation often cites sources from Europe (EMA/MHRA) and other international regions (e.g., Health Canada) confirming its authorization globally.

Q: Why do official documents sometimes mention an interaction with grapefruit?

A: The interaction is mentioned because grapefruit contains specific chemicals that can interfere with the body's metabolism (the way it breaks down) of some medicines.

This interference can potentially lead to higher levels of the medication in the body, increasing the risk of side effects.

Q: Is there any food or drink I should definitely avoid while taking Mildison?

A: Generally, official documents do not list specific food or drink restrictions for the topical product.

However, specific substances like grapefruit have been examined in studies for their potential to interfere with how some topical medications are processed by the body.

How should Mildison be stored and disposed of?

Official labeling dictates the specific conditions required for the storage and disposal of Mildison (hydrocortisone butyrate) to ensure its stability.

Storage and Disposal Requirements

Requirement Official Regulatory Statement
Temperature Store at Controlled Room Temperature between 59 F and 77 F (15 C to 25 C).
Handling Protect from freezing. Do not freeze. Store away from excessive heat, moisture, and direct light.
Container Must be kept in a tightly closed container and dispensed in a closed container.
Child Safety Keep out of the reach of children.
Disposal Ask a healthcare professional how to dispose of unused or outdated medicine. Do not throw product into wastewater or household trash.

These regulatory statements mandate storage within a specific temperature range, strict protection from freezing, and storage in an appropriate container to maintain product integrity. Discarding the product requires consultation with a healthcare professional, following official non-household waste protocols.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Mildison found in:

A-Z Index: